BIMI Holdings Inc. (BIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Nov 13, 2024, 3:00 PM EST
BIMI Holdings Revenue
BIMI Holdings had revenue of $2.52M in the quarter ending September 30, 2023, a decrease of -48.85%. This brings the company's revenue in the last twelve months to $12.63M, up 91.60% year-over-year. In the year 2022, BIMI Holdings had annual revenue of $11.83M, down -44.51%.
Revenue (ttm)
12.63M
Revenue Growth
+91.60%
P/S Ratio
0.00
Revenue / Employee
42.68K
Employees
296
Market Cap
125.65K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 104.76M |
BIMI Holdings News
- 6 months ago - BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq - GlobeNewsWire
- 11 months ago - BIMI Announces Results of 2023 Annual General Meeting of Stockholders - GlobeNewsWire
- 11 months ago - BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - BIMI Announces Buyback of Warrants - GlobeNewsWire
- 1 year ago - BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results - GlobeNewsWire
- 1 year ago - BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 1 year ago - BIMI Announces Subsidiary Phenix Bio Inc.'s New Product Launch - GlobeNewsWire
- 1 year ago - BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc's Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor - GlobeNewsWire